TBXT and neoplasm: They revealed genetic changes in known tumor-related suppressors and oncogenes such as PIK3CA, PTEN and CDKN2A as well as alterations in tissue-specific genes such as TBXT duplications and protein truncating mutations in LYST gene [4, 10].